TITLE

Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)

AUTHOR(S)
Scheiman, James M.; Devereaux, P. J.; Herlitz, Johan; Katelaris, Peter H.; Lanas, Angel; van Zanten, Sander Veldhuyzen; Naucl?(c)r, Emma; Svedberg, Lars-Erik
PUB. DATE
March 2011
SOURCE
Heart;Mar2011, Vol. 97 Issue 6, p797
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective To determine whether once-daily esomeprazole 40?�mg or 20?�mg compared with placebo reduces the incidence of peptic ulcers over 26?�weeks of treatment in patients taking low-dose acetylsalicylic acid (ASA) and who are at risk for ulcer development. Design Multinational, randomised, blinded, parallel-group, placebo-controlled trial. Setting Cardiology, primary care and gastroenterology centres (n=240). Patients Helicobacter pylori-negative patients taking daily low-dose ASA (75-325?�mg), who fulfilled one or more of the following criteria: age =18?�years with history of uncomplicated peptic ulcer; age =60?�years with either stable coronary artery disease, upper gastrointestinal symptoms and five or more gastric/duodenal erosions, or low-dose ASA treatment initiated within 1?�month of randomisation; or age =65?�years. All patients were ulcer-free at study entry. Interventions Once-daily, blinded treatment with esomeprazole 40?�mg, 20?�mg or placebo for 26?�weeks. Main outcome measures The primary end point was the occurrence of endoscopy-confirmed peptic ulcer over 26?�weeks. Results A total of 2426 patients (52% men; mean age 68?�years) were randomised. After 26?�weeks, esomeprazole 40?�mg and 20?�mg significantly reduced the cumulative proportion of patients developing peptic ulcers; 1.5% of esomeprazole 40?�mg and 1.1% of esomeprazole 20?�mg recipients, compared with 7.4% of placebo recipients, developed peptic ulcers (both p<0.0001 vs placebo). Esomeprazole was generally well tolerated. Conclusions Acid-suppressive treatment with once-daily esomeprazole 40?�mg or 20?�mg reduces the occurrence of peptic ulcers in patients at risk for ulcer development who are taking low-dose ASA.
ACCESSION #
60944664

 

Related Articles

  • Withdrawal of Clopidogrel in Active Gastric Bleeding. Mourad, Jean-Jacques; Sung, Joseph J. Y. // Annals of Internal Medicine;5/18/2010, Vol. 152 Issue 10, p685 

    A letter to the editor and a reply are presented in response to the article "Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial," by Joseph J. Y. Sung and colleagues in the 2010 issue.

  • Esomeprazole offers benefits at low-to-no cost.  // PharmacoEconomics & Outcomes News;3/6/2010, Issue 598, p6 

    The article discusses research on the cost benefits of high-dose intravenous esomeprazole against peptic ulcer, which references a study by A. N. Barkun et al, published in an issue of "PharmacoEconomics."

  • Esomeprazole Alone Compared with Esomeprazole Plus Aspirin for the Treatment of Aspirin-Related Peptic Ulcers. Liu, Chun-Peng; Chen, Wen-Chi; Lai, Kwok-Hung; Mar, Guang-Yuan; Lin, Shyr-Yi; Ger, Luo-Ping; Hsu, Ping-I // American Journal of Gastroenterology;Jul2012, Vol. 107 Issue 7, p1022 

    BACKGROUND:Aspirin-related peptic ulcers are a common disorder. However, whether or not aspirin should be continued during treatment for aspirin-related ulcers remains unclear.AIMS:To compare esomeprazole alone with esomeprazole plus aspirin in the treatment of aspirin-related peptic ulcers and...

  • Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON). Scheiman, James M.; Devereaux, P. J.; Herlitz, Johan; Katelaris, Peter H.; Lanas, Angel; van Zanten, Sander Veldhuyzen; Nauclér, Emma; Svedberg, Lars-Erik // Heart;May2011, Vol. 97 Issue 10, p5 

    The article discusses a study of the OBERON trial, a randomised, blinded parallel-group controlled trial that explored the efficacy of esomeprazole, at once-daily doses of 40mg and 20 mg for the prevention of peptic ulcers associated with continuous use of low-dose acetylalicylic acid for...

  • Ulcers bled less with omeprazole. Roberts, John; Greenberger, Norton J. // Annals of Internal Medicine;08/15/98, Vol. 129 Issue 4, p312 

    Presents a summary of the article `A Comparison of Omeprazole and Placebo for Bleeding Peptic Ulcer,' by M.S. Khuroo, G.N. Yattoo, G. Javid and others, as published in the 1997 edition of the periodical `New England Journal of Medicine.'

  • IV esomeprazole cost effective in peptic ulcer bleeding.  // PharmacoEconomics & Outcomes News;11/1/2008, Issue 565, p8 

    The article reports on a cost-effectiveness study on High-dose IV esomeprazole infusions in patients with peptic ulcer bleeding (PUB). Researchers compared the cost-effectiveness of an IV esomeprazole infusion with placebo in patients with PUB who underwent endoscopic haemostasis. An analysis of...

  • Continuing Low-dose Aspirin with Peptic Ulcer Bleeding. Ferris, Mary Elina // Internal Medicine Alert;1/29/2010, Vol. 32 Issue 2, p11 

    The article discusses the effectiveness of low-dose aspirin to treat patients with peptic ulcer bleeding.

  • Peptic Ulcer Bleeding.  // Current Medical Literature: Gastroenterology;2009, Vol. 28 Issue 3, p75 

    This article focuses on two studies that examined therapies for the prevention of peptic ulcer rebleeding. One study examined the effect of intravenous esomeprazole versus placebo following endoscopic hemostasis of gastric or duodenal ulcers with high-risk stigmata. Particular focus is given to...

  • SUMMARIES FOR PATIENTS. The Effect of Low-Dose Aspirin on Colorectal Cancer Risk in Women.  // Annals of Internal Medicine;7/16/2013, Vol. 159 Issue 2, pI-24 

    The article focuses son the report titled "Alternate-Day, Low-Dose Aspirin and Cancer Risk: Long-Term Observational Follow-up of a Randomized Trial" issued by researcher N.R. Cook and colleagues. According to the study, people taking aspirin have 20 percent lower chance of developing colorectal...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics